Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
JNJ-18038683 by Johnson & Johnson for Bipolar Disorder (Manic Depression): Likelihood of Approval
JNJ-18038683 is under clinical development by Johnson & Johnson and currently in Phase II for Bipolar Disorder (Manic Depression). According...